Sodium/Glucose Cotransporter 2 Inhibition and Urolithiasis: The Effect of Urinary pH and Citrate.
作者信息
Harmacek Dusan, Bonny Olivier
机构信息
Department of Nephrology, University Hospital of Zurich, Zurich, Switzerland.
Department of Medicine, Service of Nephrology and Hypertension, Lausanne University Hospital, Lausanne, Switzerland.
出版信息
Kidney Int Rep. 2023 Mar 24;8(6):1268. doi: 10.1016/j.ekir.2023.02.1094. eCollection 2023 Jun.
Abstract
摘要
相似文献
1
Sodium/Glucose Cotransporter 2 Inhibition and Urolithiasis: The Effect of Urinary pH and Citrate.钠/葡萄糖协同转运蛋白2抑制与尿路结石形成：尿液pH值和柠檬酸盐的影响
Kidney Int Rep. 2023 Mar 24;8(6):1268. doi: 10.1016/j.ekir.2023.02.1094. eCollection 2023 Jun.
2
Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis.尿石症患儿尿中钙离子与尿钙、柠檬酸水平和 pH 值的关系。
Pediatr Nephrol. 2013 Jul;28(7):1079-84. doi: 10.1007/s00467-013-2420-0. Epub 2013 Feb 3.
3
Effect of two sports drinks on urinary lithogenicity.两种运动饮料对尿石生成的影响。
Urol Res. 2009 Feb;37(1):41-6. doi: 10.1007/s00240-008-0166-0. Epub 2008 Dec 10.
4
Effects of sodium citrate on melamine-cyanuric acid mixture-induced urolithiasis in rats.三聚氰胺-尿酸混合物诱导大鼠尿石症中柠檬酸钠的作用。
Clin Chim Acta. 2013 Sep 23;424:76-82. doi: 10.1016/j.cca.2013.05.016. Epub 2013 May 28.
5
Potassium Citrate is Better in Reducing Salt and Increasing Urine pH than Oral Intake of Lemonade: A Cross-Over Study.枸橼酸钾降低盐摄入和增加尿 pH 值优于口服柠檬水：一项交叉研究。
Med Sci Monit. 2018 Apr 1;24:1924-1929. doi: 10.12659/msm.909319.
6
Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index.按体重指数分层的结石、低尿pH值和低枸橼酸尿症患者的治疗反应
J Urol. 2016 Mar;195(3):653-7. doi: 10.1016/j.juro.2015.09.070. Epub 2015 Sep 21.
7
[Urinary citrate excretion in children with calcium urolithiasis].[小儿钙结石患者的尿枸橼酸盐排泄]
Przegl Lek. 2006;63 Suppl 3:134-6.
8
Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls.复发性肾钙结石患者和正常对照者中肾柠檬酸钠共转运体（hNaDC-1）基因多态性与尿柠檬酸盐排泄之间的关联。
Int J Urol. 2007 Apr;14(4):344-9. doi: 10.1111/j.1442-2042.2007.01554.x.
9
Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.患有低枸橼酸尿症且尿液pH值“正常”的尿路结石患者复发风险很高。
Urol Int. 2012;88(3):294-7. doi: 10.1159/000335441. Epub 2012 Mar 7.
10
Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.化学形态解释柠檬酸盐在尿路结石病中的治疗作用：pH值升高是决定性因素。
Nephrol Dial Transplant. 2006 Feb;21(2):361-9. doi: 10.1093/ndt/gfi211. Epub 2005 Oct 25.
引用本文的文献
1
In Reply to "Letter Regarding 'Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis'".回复《关于“钠-葡萄糖协同转运蛋白2抑制剂对尿路结石的影响”的信》
Kidney Int Rep. 2023 Mar 28;8(6):1268-1269. doi: 10.1016/j.ekir.2023.03.018. eCollection 2023 Jun.
本文引用的文献
1
Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis.钠-葡萄糖协同转运蛋白2抑制剂对尿路结石的影响。
Kidney Int Rep. 2023 Feb 3;8(4):925-928. doi: 10.1016/j.ekir.2023.01.034. eCollection 2023 Apr.
2
Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate.恩格列净通过降低 pH 值和增加柠檬酸盐来改变尿液过饱和度。
J Am Soc Nephrol. 2022 Jun;33(6):1073-1075. doi: 10.1681/ASN.2021111515. Epub 2022 Apr 6.
3
Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?恩格列净与肾结石风险降低：SGLT2 抑制的潜在新作用？
J Clin Endocrinol Metab. 2022 Jun 16;107(7):e3003-e3007. doi: 10.1210/clinem/dgac154.
4
Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis.钠-葡萄糖共转运蛋白 2 抑制剂与肾结石风险。
Diabetologia. 2021 Jul;64(7):1563-1571. doi: 10.1007/s00125-021-05424-4. Epub 2021 Mar 13.
Zotero 插件